PRVA today
$23.67-$0.37 (-1.54%)close Nov 12, 2026Trend
DailyUptrend (starting)
4 hourExpanding
1 hourBearish
15 minExpanding
5 minBearish
Daily trend turns down below $18.91
Key levels
Resistance$26.71
Resistance$24.96
Support$23.41
Support$22.27
Latest news & SEC filings
ProductPrivia Health Points to Growing Use of Optain Platform
AnalystPiper Sandler keeps Overweight on Privia Health, lifts price target
AnalystCanaccord Genuity keeps Buy rating on Privia Health, lifts target to $33
AnalystPiper Sandler keeps Overweight on Privia Health, lifts target to $38
All PRVA news →About Privia Health
Privia Health is a technology-driven company that works with doctors, insurers, and hospital networks. It groups physicians into regional medical organizations and provides them with software, administrative support, and accountable care organizations. Its customers include clinicians, payers, employers, and patients, and it operates across much of the United States.
Based on the company's 10-K filed Feb 27, 2026.
Nasdaq · Healthcare
Privia Health Group, Inc. (PRVA)
What Is the Price Target for PRVA?
SEPT Low Target
$26.00
SEPT Mid Target
$33.00
SEPT High Target
$38.00
Analyst Consensus
$33.00
Is PRVA a Buy or Sell Right Now?
Thesis
- •Revenue growing 22.3% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for PRVA.
Start Free Trial →Is PRVA Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$29.07
28
Moat Score
NONE
5/9
Piotroski Score
5.0
Altman Z-Score
What Is Smart Money Doing with PRVA?
Insider Signal
SELLING
0 buys / 8 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| SOISTMAN FRANCIS S JR | director | Buy | 8,463 | - | May 20, 2026 |
| BERBERIAN LANCE | director | Buy | 8,463 | - | May 20, 2026 |
| COCOZZA NANCY G | director | Buy | 8,463 | - | May 20, 2026 |
| Kimmet Pamela O | director | Buy | 8,463 | - | May 20, 2026 |
| McCarthy Thomas A | director | Buy | 8,463 | - | May 20, 2026 |
| Morris Matthew Shawn | director | Buy | 8,463 | - | May 20, 2026 |
| Ryu Jaewon | director | Buy | 8,463 | - | May 20, 2026 |
| KING DAVID P | director | Buy | 8,463 | - | May 20, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →PRVA Growth Story
Revenue YoY
22.3%
3yr Revenue CAGR
16.1%
EPS Growth YoY
63.64%
FCF Growth YoY
N/A%
Revenue Trend
STRONG
Dark Pool Trades for PRVA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for PRVA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:30 | $23.67 | 5,218 | $$124K | SELL |
| 21:00:30 | $23.67 | 1,914 | $$45K | SELL |
| 21:00:30 | $23.67 | 5,532 | $$131K | SELL |
| 21:00:02 | $23.67 | 1,000 | $$24K | SELL |
| 21:00:00 | $23.67 | 1,905 | $$45K | BUY |
5 dark pool trades shown · $$369K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Privia Health Group, Inc. (PRVA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →PRVA — frequently asked questions
What is PRVA stock price today?
Privia Health Group, Inc. (PRVA) is at $23.67, down 1.54% (-$0.37) at the Nov 12, 2026 close.
Why is PRVA stock moving today?
Latest PRVA news — Nov 10, 2026: Privia Health Points to Growing Use of Optain Platform · Nov 6, 2026: Piper Sandler keeps Overweight on Privia Health, lifts price target
What is the PRVA price target?
The average analyst price target for PRVA is $33.00, ranging from $26 to $38, based on 3 analysts. Latest: Canaccord Genuity maintains on Nov 6, 2026.
What do analysts rate PRVA?
Analyst ratings for PRVA: 0 Buy, 5 Hold, 0 Sell — consensus Hold.
Did PRVA beat earnings?
PRVA last reported on Nov 5, 2026: EPS $0.21 vs $0.09 expected — a beat of 132.0%.
What is PRVA's P/E ratio?
PRVA trades at a P/E of 90.9 vs a Healthcare average of 17.1.
Does PRVA pay a dividend?
PRVA does not currently pay a dividend.
What are PRVA support and resistance levels?
Support: $23.41, $22.27, $20.74. Resistance: $24.96, $26.71, $27.70.
What are insiders doing with PRVA?
Insider activity: SELLING, 0 buys and 8 sells in the last 90 days.
What is the latest news on PRVA?
Nov 10, 2026: Privia Health Points to Growing Use of Optain Platform · Nov 6, 2026: Piper Sandler keeps Overweight on Privia Health, lifts price target · Nov 6, 2026: Canaccord Genuity keeps Buy rating on Privia Health, lifts target to $33